Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Azoniaspiro Compound Xvii
2. Azoniaspiro(3 Alpha-benziloyloxynortropane-8,1'- Pyrrolidine) Chloride
3. Ceris
4. Spasmex
5. Spasmo-lyt
6. Spasmo-rhoival Tc
7. Spasmo-urgenin
8. Spasmo-urgenin Tc
9. Spasmolyt
10. Trospi
11. Uraplex
12. Uraton
1. 10405-02-4
2. Sanctura
3. Spasmex
4. Relaspium
5. Spasmo-lyt
6. Uraplex
7. Sanctura Xr
8. Regurin
9. Santura
10. Trospium Cl
11. Trospii Chloridum
12. Cloruro De Trospio
13. Spasmo 3
14. Chlorure De Trospium
15. Trospium (chloride)
16. Ip631
17. Spasmoplex
18. Ip-631
19. Trospium Chloride (sanctura)
20. 1e6682427e
21. Dsstox_cid_3724
22. Dsstox_rid_77166
23. Dsstox_gsid_23724
24. Keptan
25. Azoniaspiro Compound Xvii
26. Flotros
27. As Xvii
28. Rel-(1r,3r,5s)-3-(2-hydroxy-2,2-diphenylacetoxy)spiro[bicyclo[3.2.1]octane-8,1'-pyrrolidin]-1'-ium Chloride
29. Cas-10405-02-4
30. Ncgc00167438-01
31. Ncgc00167438-02
32. Trospiumchlorid
33. Spasmed
34. Trofame
35. Trospikan
36. Trosec
37. Regurin Xl
38. Trospii Chloridum [inn-latin]
39. Cloruro De Trospio [inn-spanish]
40. Unii-1e6682427e
41. Chlorure De Trospium [inn-french]
42. [(1s,5r)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-hydroxy-2,2-diphenylacetate;chloride
43. Einecs 233-875-4
44. Trospium Chloride [usan:usp:inn:ban:jan]
45. Schembl25785
46. Trospium Chloride [mi]
47. Trospium Chloride [inn]
48. Trospium Chloride [jan]
49. Chembl3084748
50. Schembl13836646
51. Trospium Chloride [usan]
52. Chebi:32270
53. Trospium Chloride [mart.]
54. Hms3656c16
55. Hms3884h08
56. Trospium Chloride [usp-rs]
57. Trospium Chloride [who-dd]
58. Bcp23426
59. Hy-b0461
60. Tox21_112442
61. 8-alpha-benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane Chloride
62. Azoniaspiro(3-alpha-benziloyloxy-nortropan-8,1'-pyrrolidine)-chloride
63. Bdbm50540489
64. Mfcd00865254
65. S2549
66. Akos015833209
67. Tox21_112442_1
68. Ac-4235
69. Ccg-268976
70. Trospium Chloride [orange Book]
71. Trospium Chloride [ep Monograph]
72. Trospium Chloride [usp Monograph]
73. Bcp0726000291
74. Sw219146-1
75. T3305
76. I11574
77. A800884
78. W-108827
79. Q27252312
80. 3alpha-hydroxyspiro(1alphah,5alphah-nortropane-8,1'-pyrrolidinium) Chloride Benzilate
81. (1s,3r,5r)-3-[(2-hydroxy-2,2-diphenylacetyl)oxy]-8lambda(5)-azaspiro[bicyclo[3.2.1]octane-8,1'-pyrrolidin]-8-ylium Chloride
82. [(1s,5r)-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]-3-yl] 2-oxidanyl-2,2-diphenyl-ethanoate Chloride
83. 2-hydroxy-2,2-diphenylacetic Acid [(1s,5r)-3-spiro[8-azoniabicyclo[3.2.1]octane-8,1'-azolidin-1-ium]yl] Ester Chloride
84. 3.alpha.-hydroxy-spiro(1.alpha.h,5.alpha.h-nortropane-8,1'-pyrrolidinium) Chloride Benzilate
85. Rel-(1r,3r,5s)-3-(2-hydroxy-2,2-diphenylacetoxy)spiro[bicyclo[3.2.1]octane-8,1'-pyrrolidin]-1'-iumchloride
86. Spiro (8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium), 3-((hydroxydiphenylacetyl)oxy)-, Chloride, (1alpha, 3beta, 5alpha)
87. Spiro(1-alpha-h,5-alpha-h-nortropane-8,1'-pyrrolidinium), 3-alpha-hydroxy-, Chloride, Benzilate
88. Spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium), 3-((hydroxydiphenylacetyl)oxy)-, Chloride, (1.alpha., 3.beta., 5.alpha.)
89. Spiro(8-azoniabicyclo(3.2.1)octane-8,1'-pyrrolidinium, 3-((hydroxydiphenylacetyl)oxy)-, Chloride, (1alpha,3beta,5alpha)-
Molecular Weight | 428.0 g/mol |
---|---|
Molecular Formula | C25H30ClNO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 5 |
Exact Mass | 427.1914215 g/mol |
Monoisotopic Mass | 427.1914215 g/mol |
Topological Polar Surface Area | 46.5 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 553 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Sanctura |
Drug Label | SANCTURA XR is an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5). The e... |
Active Ingredient | Trospium chloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 20mg |
Market Status | Prescription |
Company | Allergan |
2 of 6 | |
---|---|
Drug Name | Sanctura xr |
Drug Label | SANCTURA XR is an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5). The e... |
Active Ingredient | Trospium chloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 60mg |
Market Status | Prescription |
Company | Allergan |
3 of 6 | |
---|---|
Drug Name | Trospium chloride |
PubMed Health | Trospium (By mouth) |
Drug Classes | Urinary Antispasmodic |
Drug Label | Trospium Chloride Extended-Release Capsules are an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, c |
Active Ingredient | Trospium chloride |
Dosage Form | Tablet; Capsule, extended release |
Route | Oral |
Strength | 60mg; 20mg |
Market Status | Prescription |
Company | Actavis Labs Fl; Apotex; Glenmark Generics; Paddock |
4 of 6 | |
---|---|
Drug Name | Sanctura |
Drug Label | SANCTURA XR is an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5). The e... |
Active Ingredient | Trospium chloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 20mg |
Market Status | Prescription |
Company | Allergan |
5 of 6 | |
---|---|
Drug Name | Sanctura xr |
Drug Label | SANCTURA XR is an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, chloride, (1, 3, 5). The e... |
Active Ingredient | Trospium chloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | 60mg |
Market Status | Prescription |
Company | Allergan |
6 of 6 | |
---|---|
Drug Name | Trospium chloride |
PubMed Health | Trospium (By mouth) |
Drug Classes | Urinary Antispasmodic |
Drug Label | Trospium Chloride Extended-Release Capsules are an extended-release formulation of trospium chloride, a quaternary ammonium compound with the chemical name of Spiro [8-azoniabicyclo[3.2.1]octane-8,1'-pyrrolidinium], 3-[(hydroxydiphenylacetyl)oxy]-, c |
Active Ingredient | Trospium chloride |
Dosage Form | Tablet; Capsule, extended release |
Route | Oral |
Strength | 60mg; 20mg |
Market Status | Prescription |
Company | Actavis Labs Fl; Apotex; Glenmark Generics; Paddock |
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
52
PharmaCompass offers a list of Trospium Chloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Trospium Chloride manufacturer or Trospium Chloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Trospium Chloride manufacturer or Trospium Chloride supplier.
PharmaCompass also assists you with knowing the Trospium Chloride API Price utilized in the formulation of products. Trospium Chloride API Price is not always fixed or binding as the Trospium Chloride Price is obtained through a variety of data sources. The Trospium Chloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride, including repackagers and relabelers. The FDA regulates 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride supplier is an individual or a company that provides 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride active pharmaceutical ingredient (API) or 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride finished formulations upon request. The 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride suppliers may include 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride API manufacturers, exporters, distributors and traders.
click here to find a list of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride DMF (Drug Master File) is a document detailing the whole manufacturing process of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride active pharmaceutical ingredient (API) in detail. Different forms of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride DMFs exist exist since differing nations have different regulations, such as 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride DMF submitted to regulatory agencies in the US is known as a USDMF. 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride USDMF includes data on 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride suppliers with USDMF on PharmaCompass.
A 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CEP of the European Pharmacopoeia monograph is often referred to as a 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride Certificate of Suitability (COS). The purpose of a 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride to their clients by showing that a 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CEP has been issued for it. The manufacturer submits a 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CEP holder for the record. Additionally, the data presented in the 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride DMF.
A 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride suppliers with CEP (COS) on PharmaCompass.
A 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride written confirmation (8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride WC) is an official document issued by a regulatory agency to a 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride manufacturer, verifying that the manufacturing facility of a 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride APIs or 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride finished pharmaceutical products to another nation, regulatory agencies frequently require a 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride WC (written confirmation) as part of the regulatory process.
click here to find a list of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride suppliers with NDC on PharmaCompass.
8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride GMP manufacturer or 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride GMP API supplier for your needs.
A 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CoA (Certificate of Analysis) is a formal document that attests to 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride's compliance with 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride specifications and serves as a tool for batch-level quality control.
8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CoA mostly includes findings from lab analyses of a specific batch. For each 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride may be tested according to a variety of international standards, such as European Pharmacopoeia (8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride EP), 8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (8-alpha-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride USP).